These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Comment on: Clinical benefits of ezetimibe: absence of proof is just that. Doggrell SA Expert Opin Pharmacother; 2013 Dec; 14(18):2611-2. PubMed ID: 24160556 [No Abstract] [Full Text] [Related]
3. Letter to the Editor: The ezetimibe 'controversy' is a misunderstanding. Spence JD Expert Opin Pharmacother; 2012 Dec; 13(17):2579-80; author reply 2580. PubMed ID: 22998481 [No Abstract] [Full Text] [Related]
4. Clinical benefits of ezetimibe use: is absence of proof, proof of absence? Gouni-Berthold I; Mikhailidis DP; Rizzo M Expert Opin Pharmacother; 2012 Oct; 13(14):1985-8. PubMed ID: 22946714 [No Abstract] [Full Text] [Related]
5. Zetia and Zocor: good together? New combo pill Vytorin may help some reach low LDL goals. Harv Health Lett; 2005 Feb; 30(4):3. PubMed ID: 15776505 [No Abstract] [Full Text] [Related]
7. Dose-comparison study of the combination of ezetimibe and simvastatin (Vytorin) versus atorvastatin in patients with hypercholesterolemia: the Vytorin Versus Atorvastatin (VYVA) Study. Galin ID; Smith DA Am Heart J; 2006 May; 151(5):e1. PubMed ID: 16644302 [No Abstract] [Full Text] [Related]
10. Ezetimibe/simvastatin: a guide to its clinical use in hypercholesterolemia. Lyseng-Williamson KA Am J Cardiovasc Drugs; 2012 Feb; 12(1):49-56. PubMed ID: 22208355 [TBL] [Abstract][Full Text] [Related]
11. Utility of ezetimibe. Ashikaga H; Blumenthal RS; Jones SR Am J Cardiol; 2009 May; 103(9):1321-2. PubMed ID: 19406279 [No Abstract] [Full Text] [Related]
12. The effect of simvastatin alone versus simvastatin plus ezetimibe on the concentration of small dense low-density lipoprotein cholesterol in subjects with primary hypercholesterolemia. Florentin M; Liberopoulos EN; Moutzouri E; Rizos CV; Tselepis AD; Elisaf MS Curr Med Res Opin; 2011 Mar; 27(3):685-92. PubMed ID: 21271793 [TBL] [Abstract][Full Text] [Related]
13. [Statin and absorption inhibitor work synergistically. More risk patient reach LDL cholesterol goal value]. MMW Fortschr Med; 2007 Apr; 149(17):56-7. PubMed ID: 17674912 [No Abstract] [Full Text] [Related]
14. The IMPROVE-IT study and ezetimibe. Signy J; Signy M Br J Community Nurs; 2015 May; 20(5):243-4. PubMed ID: 25993373 [No Abstract] [Full Text] [Related]
15. Effect of ezetimibe/simvastatin compared with atorvastatin on lipoprotein subclasses in patients with type 2 diabetes and hypercholesterolaemia. Tomassini JE; Mazzone T; Goldberg RB; Guyton JR; Weinstock RS; Polis A; Jensen E; Tershakovec AM Diabetes Obes Metab; 2009 Sep; 11(9):855-64. PubMed ID: 19508464 [TBL] [Abstract][Full Text] [Related]
16. Simvastatin + ezetimibe: a combination with no proven advantages. Prescrire Int; 2007 Apr; 16(88):67. PubMed ID: 17460829 [No Abstract] [Full Text] [Related]
17. The ezetimibe controversy - can this be resolved by comparing the clinical trials with simvastatin and ezetimibe alone and together? Doggrell SA Expert Opin Pharmacother; 2012 Jul; 13(10):1469-80. PubMed ID: 22725704 [TBL] [Abstract][Full Text] [Related]
18. [Target values are more often attainable. Almost doubly so many patients with values under 100mg/dl]. MMW Fortschr Med; 2004 Oct; 146(44):57. PubMed ID: 15566254 [No Abstract] [Full Text] [Related]
19. Comparison of effects of morning versus evening administration of ezetimibe/simvastatin on serum cholesterol in patients with primary hypercholesterolemia. Yoon HS; Kim SH; Kim JK; Ko SH; Ko JE; Park SJ; Park MG; Lee JH; Hyon MS Ann Pharmacother; 2011 Jul; 45(7-8):841-9. PubMed ID: 21693699 [TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of ezetimibe co-administered with simvastatin compared with atorvastatin in adults with hypercholesterolemia. Ballantyne CM; Blazing MA; King TR; Brady WE; Palmisano J Am J Cardiol; 2004 Jun; 93(12):1487-94. PubMed ID: 15194018 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]